178 related articles for article (PubMed ID: 1864979)
1. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
Levy Y; Tsapis A; Brouet JC
J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
3. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
4. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
[TBL] [Abstract][Full Text] [Related]
5. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
Kong B; Isozaki T; Sasaki S
Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
Burch RM; Mahan LC
J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
10. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
Watson JM; Berek JS; Martínez-Maza O
Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
[TBL] [Abstract][Full Text] [Related]
12. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
13. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
[TBL] [Abstract][Full Text] [Related]
14. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
15. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
Takahashi T; Okuno Y; Ohsugi Y
Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
[TBL] [Abstract][Full Text] [Related]
17. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
Rogers SY; Bradbury D; Kozlowski R; Russell NH
Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
[TBL] [Abstract][Full Text] [Related]
18. A novel and rapid prediction assay for the effectiveness of IL-6 receptor specific antisense oligonucleotides by proliferation inhibition of an interleukin-6 dependent cell line.
Lia Varga V; Falus A; Pallinger E; Novák I; Fülöp KA; Toth S; Rose-John S
Cell Biol Int; 2001; 25(3):253-6. PubMed ID: 11352498
[TBL] [Abstract][Full Text] [Related]
19. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
20. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]